14 March 2025 in Smart Molecules
Emerging therapies rely on the efficient and specific delivery of targeted agents into the cytosol, such as DNA, siRNA and proteins. Nanoparticles showed great potentials in safe delivery and transportation of the targeted cargoes; however, the entrapment in endosomes and degradation by specific enzymes in the lysosome hindered the bioavailability, cytosolic delivery and subsequent therapeutic efficacy. In this case, the development of methods for efficient and specific delivery of targeted therapeutic agents focuses on overcoming the major challenge of endo/lysosomal escape, which relies on the development of safe and efficient nano‐delivery systems. A deeper mechanistic understanding in the endo/lysosomal escape will guide the development of more efficient nano‐delivery systems. In this review, we summarize various mechanisms by which nanoparticles escape from the endo/lysosome, and showcase the recent progress in dissecting the endo/lysosomal approaches based on nano‐delivery systems. Emphasis will lie on the properties of nanoparticles that govern the endo/lysosomal escape pathway as well as the latest promising applications in vaccine delivery and genetic engineering field.
12 September 2024 in Advanced Materials
Nucleic acid nanostructures, derived from the assembly of nucleic acid building blocks (e.g., plasmids and oligonucleotides), are important intracellular carriers of therapeutic cargoes widely utilized in preclinical nanomedicine applications, yet their clinical translation remains scarce. In the era of “translational nucleic acid nanotechnology”, a deeper mechanistic understanding of the interactions of nucleic acid nanostructures with cells in vivo will guide the development of more efficacious nanomedicines. This review showcases the recent progress in dissecting the in vivo interactions of four key types of nucleic acid nanostructures (i.e., tile‐based, origami, spherical nucleic acid, and nucleic acid nanogel) with cells in rodents over the past five years. Emphasis lies on the cellular‐level distribution of nucleic acid nanostructures in various organs and tissues and the cellular responses induced by their cellular entry. Next, in the spirit of preclinical translation, this review features the latest interactions of nucleic acid nanostructures with cells in large animals and humans. Finally, the review offers directions for studying the interactions of nucleic acid nanostructures with cells from both materials and biology perspectives and concludes with some regulatory updates.
12 December 2021 in ACS Applied Materials & Interfaces
14 August 2022 in Biomaterials